Reauthorizing the Kay Hagan Tick Act
The House considered H.R. 4348, a bill to reauthorize the Kay Hagan Tick Act, which continues CDC programs through FY2030 addressing vector-borne diseases such as Lyme disease, including a national strategy, regional centers of excellence, and grants to state, local, and tribal health departments. Members of both parties spoke in support, citing the rise in Lyme and other tick-borne illnesses and the need for continued research and local public health funding. Members thanked the bill’s lead sponsors, Representatives Smith, Doggett, Kean, and Tonko, and encouraged a yes vote under suspension of the rules.Written by AI from the debate. Updated .
No matching statements
No statements match this filter
Choose another party or return to all statements.
More from issue 118
- House of Representatives Honoring Life of Douglas Graham 4 statements
- House of Representatives Recognizing Larry "the Grinch" Stone 2 statements
- House of Representatives Commemorating 82nd Anniversary of Liberation of Guam 2 statements
- House of Representatives Choices for Increased Mobility Act of 2026 5 statements
- House of Representatives Destruction of Hazardous Imports Act 6 statements
- House of Representatives FDA Modernization Act 3.0 6 statements
- House of Representatives Reauthorizing the Kay Hagan Tick Act 6 statements
- House of Representatives Stem Cell Therapeutic and Research Reauthorization Act of 2025 6 statements
- House of Representatives Accelerating Access to Dementia and Alzheimer's Provider Training Act 6 statements
- House of Representatives Action for Dental Health Act 7 statements
- House of Representatives Programs to Prevent, Detect, and Treat Traumatic Brain Injuries 4 statements
- House of Representatives Early Act Reauthorization of 2025 7 statements
- House of Representatives Deondra Dixon Include Project Act of 2025 5 statements
- House of Representatives NIH Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone Act 7 statements
- House of Representatives Accelerating Access to Critical Therapies for Als Reauthorization Act of 2026 6 statements
- House of Representatives Putting Patients First by Strengthening Provider Accountability in Feca Act 6 statements
- House of Representatives Value over Cost Act of 2026 3 statements
- House of Representatives Ensuring Federal Purchasing Efficiency Act 6 statements
- House of Representatives Stop Secret Spending Act of 2025 6 statements
- House of Representatives Federal Improvement in Technology Procurement Act 4 statements
- House of Representatives Federal Relocation Payment Improvement Act 5 statements
- House of Representatives Billion Dollar Boondoggle Act 5 statements
- House of Representatives Expanding Whistleblower Protections for Contractors Act of 2026 3 statements
- House of Representatives Nucleic Acid Standards for Biosecurity Act 5 statements
- House of Representatives Next-Generation Geothermal Research and Development Act 7 statements
- House of Representatives Recognizing 100th Anniversary of Long Island Association 9 statements
- House of Representatives Honoring the Life and Legacy of Congressman John Lewis 4 statements
- Senate Cloture Motion (Executive Calendar) 2 statements
- Senate Order for Adjournment 17 statements